Led $50M financing for Nucleus RadioPharma to expand radiopharmaceutical manufacturing capacity.
Nucleus RadioPharma is an end-to-end contract development and manufacturing organization (CDMO) dedicated to building robust clinical and commercial supply chains for targeted radiotherapies, ensuring patients receive optimal therapies efficiently
Nucleus RadioPharma is an end-to-end contract development and manufacturing organization (CDMO) dedicated to building robust clinical and commercial supply chains for targeted radiotherapies, ensuring patients receive optimal therapies efficiently.